Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The antigen presentation pathway in virus-infected host cells is a critical component of the immune system’s ability to detect and respond to intracellular pathogens. In this pathway, viral proteins synthesized in the host cell are processed by the proteasome into peptides. These peptides are transported into the endoplasmic reticulum and loaded onto MHC class I molecules, which then migrate to the cell surface. Here, the peptide-MHC complexes can be recognized by CD8+ cytotoxic T cells, initiating an immune response that eliminates infected cells. Viruses frequently interfere with various steps of this pathway to evade immune recognition. The pathway’s proper function is essential for antiviral immunity, as well as relevant in cancer, autoimmunity, and immune-based therapies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antigen presentation pathway (virus-infected host cell).